Somatic gene therapy and its implications in melanoma treatment

Archives of Dermatological Research

Volumn 289, Issue 2, 1997, Pages 71-77

  Möller, Peter ^a   Schadendorf, Dirk ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

CANCER IMMUNOTHERAPY; GENE THERAPY; GENE TRANSFER; MELANOMA; PRIORITY JOURNAL; REVIEW;

CLINICAL TRIALS; DNA, VIRAL; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; MELANOMA;

EID: 0031020340     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050157     Document Type: Review

References (67)

1. Ahmann DL, Creagan ET, Hahn RG, Edmonson JH, Bisel HF, Schaid DJ (1989) Complete responses and long-term survivals after systemic chemotherapy for patients with advanced malignant melanoma. Cancer 63:224-227
2. Albino AP, Davis BM, Nanus DM (1991) Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res 51:4815-4820
3. Alijagic S, Möller P, Artuc M, Jurgovsky K, Czarnetzki BM, Schadendorf D (1995) Transfection of dendritic cells generated from peripheral blood with human tyrosinase induced specific T-cell activation. Eur J Immunol 25:3100-3107
4. Beissert S, Hosoi J, Grabbe S, Asahina A, Granstein RD (1995) IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells. J Immunol 154:1280-1288
5. Blankenstein T (1994) Increasing tumour immunogenicity by genetic modification. Eur J Cancer 30A:1182-1187
6. Boon T, Gajewski T F, Coulie PG (1995) From defined human tumor antigens to effective immunization. Immunol Today 16: 334-336
7. Calabretta B, Skorski T, Szczylik C, and Zon G (1993). Prospects for gene-directed therapy with antisense oligonucleotides. Cancer Treat Rev 19:169-179
8. Cayeux S, Beck C, Aicher A, Dörken B, Blankenstein T (1995) Tumor cells cotransfected with interleukin-7 and B7.1 genes induce CD25 and CD28 on tumor-infiltrating T lymphocytes and are strong vaccines. Eur J Immunol 25:2325-2331
9. Chen L, Ashe S, Brady WA, Hellström I, Hellström KE, Ledbetter JA, Mc Gowan P, and Linsley PS (1992) Costimulation of antitumor Immunity by the B7 counterreceptor for T lymphocyte molecules CD28 and CTLA-4. Cell 71:1093-1102
10. Colombo MP, Forni G (1994) Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now? Immunol Today 15:48-51
11. Colombo MP, Maccalli C, Mattei S, Melani C, Radrizzani M, Parmiani G (1992) Expression of cytokine genes, including IL-6, in human malignant melanoma cell lines. Melanoma Res 2:181-189
12. Culver KW (1995) The June 1995 RAC meeting. Gene Ther Newslett 12:1-2
13. Culver KW (1996) Measuring succes in clinical gene therapy research. Mol Med Today 6:234-236
14. Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, Agrcola B, Byrne E, Raffeld M, Moen R, Bacher J, Zsebo KM, Nienhuis AW (1992) Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 176:1125-1135
15. Dummer R, Gore M, Hancock B, Guillou P, Grobben H, Becker J, Oscam R, Dieleman J, Burg G (1995) A multicenter phase II clinical trial using dacarbazine and continuous infusion of interleukin-2 in metastatic melanoma: clinical data and immunomonitoring. Cancer 75:1038-1044
16. Falkson CI, Falkson G, Falkson HC (1991) Improved results with the addition of interferon-alpha-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma. J Clin Oncol 9:1403-1408
17. Fearon ER., Pardoll DM, Itaya T, Golumbek P, Livitsky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P (1990) Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60:397-403
18. Fearon ER, Itaya T, Hunt B, Vogelstein B, and Frost P (1988) Induction in a murine tumor of immunogeneic tumor variants by transfection with a foreign gene. Cancer Res. 48:2975-2980
19. Ferrone S (1994) Melanoma, immune surveillance, and immunotherapy. J Clin Invest 93:1351-1352
20. Friedmann T (1996) Human gene therapy-an immature genie, but certainly out of the bottle. Nature Med 2:144-147
21. Gilboa E, Lyerly HK (1994) Specific active immunotherapy of cancer using genetically modified tumor vaccines. Biologic therapy of cancer updates 4:1-16
22. Grabbe, S, Beissert S, Schwarz T, Granstein RD (1995) Dendritic cells as initiators of tumor immune responses: a possible strategy for immunotherapy? Immunol Today 16:117-121
23. Günzburg WH, Salmons B (1995) Virus vector design in gene-therapy. Mol Med Today 1:410-417
24. Hengge UR, Chan EF, Foster RA, Walker PS, Vogel JC (1995) Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nature Genetics 10:161-166
25. Ho VC, Sober AJ (1990) Therapy of cutaneous melanoma: an update. J Am Acad Dermatol 22:159-176
26. d). Cancer Res 47:3136-3141
27. Kamb A, Gruis NA, Weaver FJ, Liu Q, Harhman K, Tavtigian SV, Stockert E, Day R, Johnson BE, and Skolnick MH (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264:436-440
28. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T, Rosenberg SA (1994). Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 91:6458-6462
29. Knowles MR, Hohneker KW, Zhou Z, Olson JC, Noah TL, Hu P, Leigh MW, Engelhardt JF, Edwards LJ, Jones KR, Grossman M, Wilson JM, Johnson LG, Boucher RC (1995) A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 333:823-831
30. Krüger-Krasagakes S, Krasagakis K, Garbe C, Schmitt E, Hüls C, Blankenstein T, Diamantstein T (1995) Expression of interleukin 10 in human melanoma. Br J Cancer 70:1182-1185
31. Ledley FD (1995) Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 6:1129-1144
32. Mackensen A, Carcelain G, Viel S, Raynal M-C, Michalaki H, Triebel F, Bosq J, Hercend T (1994) Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Invest 93:1391-1402
33. Maeurer MJ, Storkus WJ, Kirkwood JM, Lotze MT (1996) New treatment options for patients with melanoma: review of melanoma-derived T-cell epitope-based peptide vaccines. Melanoma Res 6:11-24
34. Marchand M, Weynants P, Rankin E, Arienti F, Belli F, Parmiani G, Cascinelli N, Bourland A, Vanwijck R, Humblet Y, Canon JL, Laurent C, Naeyaert JM, Plagne R, Deraemaeker R, Knuth A, Jäger E, Brasseur F, Herman J, Coulie PG Boon T (1995) Tumor regression responses in melanoma patients with a peptide encoded by gene MAGE-3. Int J Cancer 63:883-885
35. Möller P, Sun YS, Dorbic T, Möller H, Makki A, Jurgovsky K, Schroff M, Henz BM, Wittig B, Schadendorf D (1997) Vaccination with IL-7-gene modified autologous tumor cells enhances tumor-specific T cell precursor frequency and modulates cytokine secretion in patients with advanced malignant melanoma- A clinical phase I study. Hum Gene Ther (in press)
36. Morgan RA, Anderson WF (1993) Human gene therapy. Annu Rev Biochem 62:191-217
37. Mulligan RC (1993) The basic science of gene therapy. Science 260:926-932
38. Nabel G J, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang I, Shu S, Gordon D, Chang AE (1993) Direct gene transfer with DNA liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 90:11307-11311
39. Pardoll DM, Beckerleg AM (1995) Exposing the immunology of naked DNA vaccines. Immunity 3:165-169
40. Parmiani G, Colombo MP (1995) Somatic gene therapy of human melanoma: preclinical studies and early clinical trials. Melanoma Res 5:295-301
41. Raz E, Carson DA, Parker SE, Parr TB, Abai AM, Aichinger G, Gromkowski SH, Singh M, Lew D, Yanakauckas MA, Baird SM, Rhodes GH (1994) Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 91:9519-9523
42. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD (1992) Restoration od viral immunity in immunodeficient humans by adoptive transfer of T cell clones. Science 257:238-241
43. Robbins PF, El-Gamil M, Kawakami Y, Rosenberg SA (1994) Recognition of tyrosinase by tumor-infiltrating lymphocytes from a patient responding to immunotherapy. Cancer Res 54: 3124-3126
44. Rogers S (1976) Reflections on issues posed by recombinant DNA molecule technology. II Ann New York Acad Sci 265: 66-70
45. Rosenberg SA, Aebersold P, Cornetta K, Kasid R, Morgan R, Moen E, Karson E, Lotze M, Yang J, Topalian S, Merino M, Culver K, Miller AD, Blaese M, Anderson WF (1990) Gene transfer into humans: immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 325:570-578
46. Rosenberg SA (1992) The immunotherapy and gene therapy of cancer. J Clin Oncol 10:180-199
47. Rosenberg SA, Lotze MT, Muul L.M, Leitman S, Chang AE, Ettinhhausen SE, Matory YLJM, Shilow E, Vetto JF (1985) Observation on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with cancer. N Engl J Med 313:1485-1492
48. Ruiter DJ, Mattijssen V, Bröcker E-B, Ferrone S (1991) MHC antigens in human melanomas Semin Cancer Biol 2:35-45
49. Schadendorf D (1997) Cytokines, autologous cell immunostimulatory and gene therapy for cancer treatment. In: Bos JD (ed) Skin immune system, 2nd edn. CRC Press Inc. (in press)
50. Schadendorf D, Czarnetzki BM, Wittig B (1995) Clinical Protocol - Interleukin-7-, interleukin-12-, and GM-CSF gene transfer in patients with metastatic melanoma. J Mol Med 73:473-477
51. Schadendorf D, Henz BM, Wittig B (1996) Interleukin 7 trials for melanoma treatment. Mol Med Today 2:143-144
52. Schadendorf D, Makki A, Stahr C, Van Dyck A, Wanner R, Scheffer GL, Flens MJ, Scheper R, Czarnetzki BM (1995) Membrane transport proteins associted with drug resistance expressed in human melanoma. Am J Pathol 147:1545-1552
53. Schadendorf D, Worm M, Algermissen B, Kohlmus C M, Czarnetzki BM (1994) Chemosensitivity testing of human melanoma cells - retrospective analysis of clinical response and in vitro drug sensitivity. Cancer 73:103-108
54. Schmidt-Wolf IGH, Neubauer A, Finke S, Csipai M, Wittig B, Huhn D (1994) Interleukin-7 gene transfer in patients with metastatic colon carcinoma, renal carcinoma, melanoma or with lymphoma. Hum Gene Therapy 5:1161-1168
55. Tang D, DeVit M, Johnston SA (1992) Genetic immunization is a simple method for eliciting an immune response. Nature 356:152-154
56. Tepper RI, Pattengale PK, Leder P (1989) Murine interleukin 4 displays potent anti-tumor activity in vivo. Cell 57:503-512
57. 1 cDNA escapes immune surveillance. Proc Natl Acad Sci USA 87:1486-1490
58. Treisman J, Hwu P, Yannelli JR, Shafer GE, Cowherd R, Samid D, Rosenberg SA (1994) Upregulation of tumor necrosis factor-alpha production by retrovirally transduced human tumor-infiltrtating lymphocytes using trans-retinoic acid. Cell Immunol 156:448-457
59. Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Feigner PL, Dwarki VJ, Gromkowski SH, Deck RR, De Witt CM, Friedman A, Hawe LA, Leander KR, Martinez D, Perry HC, Shiver JW, Montgomery DL, Liu MA (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749
60. van Lohuizen M, Berns A (1990) Tumorigenesis by slow-transforming retroviruses-an update. Biochim Biophys Acta 1032:213-235
61. Veelken H, Jesuiter H, Mackensen A, Kulmburg P, Schultze J, Rosenthal F, Mertelsmann R, Lindemann A (1994) Primary fibroblasts from human adults as target cells for ex vivo transfection and gene therapy. Hum Gene Ther 5:1203-1210
62. Vieweg J, Gilboa E (1995) Considerations for the use of cytokine-secreting tumor cell preparations for cancer treatment. Cancer Invest 13:193-201
63. Vile RG, Hart IR (1993) Use of tissue-specific expression of the herpes simplex virus thymidine kinase gene to inhibit growth of established murine melanomas following direct intratumoral injection of DNA. Cancer Res 53:3860-3864
64. Vujanovic NL, Yasumura S, Hirabayashi H, Lin W, Watkins S, Herberman RB, and Whiteside TL (1995) Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues. J Immunol 154:281-289
65. Whittington R, Faulds D (1993) Interleukin-2 - a review of its pharmacological properties and therapeutic use in patients with cancer. Drugs 46:446-514
66. Wolff JA, Malone RW, Williams P, Chong W, Ascadi G, Jani A, Feigner PL (1990) Direct gene transfer into mouse muscle in vivo. Science 247:1465-1468
67. Yasumura S, Lin W, Hirabayashi H, Vujanovic NL, Herberman RB, Whiteside TL (1994) Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells. Cancer Res 54:3808-3816